SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-048123
Filing Date
2006-03-08
Accepted
2006-03-08 13:27:20
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 576927
2 PLACEMENT AGENCY AGREEMENT dex106.htm EX-10.6 68172
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 5996
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6013
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 2756
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 2920
  Complete submission text file 0001193125-06-048123.txt   664276
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51462 | Film No.: 06672435
SIC: 2836 Biological Products, (No Diagnostic Substances)